Antigen

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

by

The Future of Automated Immunoassays in Biopharmaceuticals With rapid advancements in biopharmaceutical technologies, automated immunoassays, like those offered by Gyros Protein Technologies, have become indispensable in ensuring the quality, consistency, and safety of biotherapeutics. The new Gyrolab HEK293 HCP Type SN and CL Kit Reagents are a testament to what the future holds for host … Read more

New AI tool promises faster vaccine development by predicting T cell epitopes

by

Revolutionizing Vaccine Development with AI The groundbreaking collaboration between the Ragon Institute and the Jameel Clinic at MIT illustrates the transformative potential of artificial intelligence in healthcare. Their development of MUNIS—a deep learning tool—positions AI as a key player in predicting CD8+ T cell epitopes with astounding precision, a leap that could significantly expedite vaccine … Read more

New delivery system could improve the effectiveness of peptide-based cancer vaccines

by

Revolutionizing Cancer Treatment: The Future of Lipopeptide Hydrogels (LPHs) Recent advancements in cancer research are increasingly focusing on innovative approaches to enhance the effectiveness of cancer vaccines. Among these innovations, lipopeptide hydrogels (LPHs) have emerged as a groundbreaking solution with the potential to transform how we tackle cancer globally. Enhancing Immune Response with Novel Materials … Read more

New guidelines for hepatitis B virus reactivation management

by

Advancements in Immunosuppressive Therapy Recent breakthroughs in immunosuppressive therapy have ushered in a new era for managing immunosuppressed patients, particularly those at risk of hepatitis B virus (HBV) reactivation. New immunosuppressive agents, such as immune checkpoint inhibitors, anti-interleukin therapies, and chimeric antigen receptor T-cell (CAR-T) therapies, provide patients with options that were not previously available. … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com